Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Oramed Pharmaceuticals Inc. (ORMP) had Return on Investments of -5.46% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$2.00M |
|
$-7.64M |
|
$1.99M |
|
$0.01M |
|
$6.50M |
|
$-4.50M |
|
$-2.56M |
|
$-7.06M |
|
$-7.06M |
|
$-7.64M |
|
$-7.64M |
|
$-7.64M |
|
$-7.64M |
|
$-4.50M |
|
$-4.47M |
|
41.23M |
|
41.23M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$131.48M |
|
$0.67M |
|
$16.06M |
|
$147.54M |
|
$5.49M |
|
-- |
|
$2.15M |
|
$7.64M |
|
$139.89M |
|
$139.89M |
|
$139.89M |
|
40.85M |
|
| Cash Flow Statement Financials | |
$-3.52M |
|
$23.62M |
|
-- |
|
$54.42M |
|
$74.52M |
|
$20.10M |
|
$2.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.65% |
|
-225.00% |
|
-225.00% |
|
-- |
|
-352.90% |
|
-382.10% |
|
$-3.52M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-5.46% |
|
-5.46% |
|
-5.18% |
|
|
Return on Investments |
-5.46% |
$3.42 |
|
$-0.09 |
|
$-0.09 |
|